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Inactivation of NUPR1 promotes 
cell death by coupling ER-stress 
responses with necrosis
Patricia Santofimia-Castaño1, Wenjun Lan1, Jennifer Bintz  1, Odile Gayet1, Alice Carrier1, 
Gwen Lomberk  2, José Luis Neira3, Antonio González4, Raul Urrutia  2, Philippe Soubeyran1 
& Juan Iovanna1
It was already described that genetic inhibition of NUPR1 induces tumor growth arrest. In this paper we 
studied the metabolism changes after NUPR1 downregulation in pancreatic cancer cells, which results 
in a significant decrease of OXPHOS activity with a concomitant lower ATP production which precedes 
the necrotic cell death. We demonstrated that NUPR1 downregulation induces a mitochondrial 
failure with a loss of the mitochondrial membrane potential, a strong increase in ROS production and 
a concomitant relocalization of mitochondria to the vicinity of the endoplasmic reticulum (ER). In 
addition, the transcriptomic analysis of NUPR1-deficient cells shows a decrease in the expression of 
some ER stress response-associated genes. Indeed, in ER stressors-treated cells with thapsigargin, 
brefeldin A or tunicamycin, a greater increase in necrosis and decrease of ATP content was observed in 
NUPR1-defficent cells. Finally, in vivo experiments, using acute pancreatitis which induces ER stress 
as well as NUPR1 activation, we observed that NUPR1 expression protects acinar cells from necrosis in 
mice. Importantly, we also report that the cell death observed after knocking-down NUPR1 expression 
is completely reversed by incubation with Necrostatin-1, but not by inhibiting caspase activity with 
Z-VAD-FMK. Altogether, these data enable us to describe a model in which inactivation of NUPR1 in 
pancreatic cancer cells results in an ER stress that induces a mitochondrial malfunction, a deficient ATP 
production and, as consequence, the cell death mediated by a programmed necrosis.
NUPR1 is a stress-inducible 82-aminoacids long, intrinsically disordered member of the AT-hook family of 
chromatin proteins. NUPR1 was first described as being activated in the exocrine pancreas in response to the 
cellular injury induced by pancreatitis1, an inflammatory disease, which in its chronic form, behaves as a prene-
oplastic condition for pancreatic cancer. Subsequently, the inducible expression of Nupr1 was discovered to be 
a surrogate of the stress response caused by many stimuli in most cell types2 characterizing NUPR1 as a typical 
stress-associated chromatin protein. NUPR1 binds to DNA in a similar manner to other chromatin proteins3,4 so 
as to control the expression of gene targets5. At the cellular level NUPR1 participates in many cancer-associated 
process including cell-cycle regulation, apoptosis6,7, cell migration and invasion8, and DNA repair responses9. 
Indeed, NUPR1 has recently elicited significant attention due to its role in promoting cancer development and 
progression in the pancreas5,10. NUPR1-dependent effects also mediate resistance to anticancer drugs11–13, an 
important characteristic of this malignancy. We8,14 and others15–19 have shown that genetic inactivation of Nupr1 
antagonizes the growth of tumors in several tissues, including pancreatic cancer8 thereby supporting a role for 
this protein as a promising therapeutic target for the development of therapies for pancreatic cancer. Congruently, 
using a comprehensive approach that combines biophysical, biochemical, computational, and biological methods 
for repurposing FDA approved drugs in the treatment of pancreatic cancer, we have recently identified that the 
phenothiazine derivative, trifluoperazine, mimics the effect of the genetic inactivation of NUPR1, revealing its 
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Figure 1. Nupr1 protects from cell death in stress situations in vitro. MiaPaCa2 cells were transfected with siCtrl 
or two different siNupr1 for 48 h. Cells were then incubated with thapsigargin, brefeldin A, or tunicamycin at 1 μM, 
for another 24 h in the presence or not of Z-VAD-FMK 10 μM or Nec-1 (40 μM). LDH release was measured  
(A); data values were normalized to the untreated siCtrl. In transfected MiaPaCa2 cells, flow cytometry analysis 
of annexin-V and PI staining following 24 h of treatment with thapsigargin, brefeldin A, or tunicamycin, showing 
% of PI-positive cells (B), annexin V-positive cells (C) and a representative experiment of the dot plot profile of 
cells (D). Data are means of triplicates ± SEM. For each treatment, statistically significant differences (*p < 0.05, 
**p < 0.01, ***p < 0.001) compared to siCtrl with same treatment conditions (#p < 0.05, ##p < 0.01, ###p < 0.001) 
compared to non-pretreated cells with Z-VAD-FMK or Nec-1 with same ER-stressor treatment. Three Panc-1 
control clones (with wild-type NUPR1) and 6 Nupr1 knockout clones, developed using CRISPR-Cas9 technology, 
were cultured in DMEM and incubated with thapsigargin, brefeldin A, or tunicamycin at 1 μM for 24 h. Flow 
cytometry analysis was carried out after Annexin-V and PI staining. The percentage of PI-positive cells  
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anticancer properties20. The current study was designed to better understand the mechanisms by which target-
ing NUPR1 results in its tumor growth-inhibiting effects. We focused on determining the specific intracellular 
pathways that result in cell death after Nupr1 inactivation in vivo (Nupr1-deficient mice) and in vitro (knock-
down by either siRNA or CRISPR-Cas9). We found that in NUPR1-deficient cells, glucose consumption was 
switched from OXPHOS towards glycolysis resulting in a significantly reduced ATP production that promoted 
a caspase-independent programmed necrotic process. This defect was due to a mitochondrial malfunction, 
which in turn resulted from a strong ER stress. This report constitutes the first demonstration that inactivation 
of NUPR1 antagonizes cell growth by coupling two pathobiological cell phenomena, namely ER-stress response 
and caspase-independent necrosis.
Results
Genetic down-regulation of NUPR1 induces pancreatic cell death by programmed necrosis. I 
n several in vitro and in vivo models of pancreatic cancer, NUPR1 down-regulation inhibits the development and 
growth of this malignant tumor, highlighting the translational importance of this protein. However, the molec-
ular mechanisms underlying these phenomena remain poorly understood. Previous work has demonstrated 
that Nupr1 expression is rapidly and significantly induced by endoplasmic reticulum (ER) stress21,22. We there-
fore, evaluated the role of NUPR1 during ER stress by inhibiting its expression in ER-stressed cells. To carefully 
define this phenomenon, ER stress on pancreatic cancer cells (MiaPaCa2) was induced by using brefeldin A, 
thapsigargin or tunicamycin in combination with decreasing of the levels of NUPR1 using two different siRNAs 
(Fig. S1A). Subsequently, the necrotic and the apoptotic effects were measured through LDH release and caspase 
3/7 activity, respectively. We found that LDH release was significantly higher in NUPR1 siRNA-transfected cells 
than in control cells, both in non-treated and ER-stressor treated cells (Fig. 1A). Moreover, ER-stressors induced a 
significant increase of LDH release compared with untreated cells both in control cells and NUPR1-dowregulated 
cells. Similarly, caspase 3/7 activity was also greater in NUPR1-depleted cells both in basal conditions and upon 
ER stress-induction (Fig. S2A). Combined, these experiments demonstrated that NUPR1 exerts both anti-ap-
optotic and anti-necrotic effects even in basal conditions, as well as during ER stress. Interestingly, pretreatment 
with the pan-caspase inhibitor, zVAD-FMK, did not prevent LDH release, as shown in Fig. 1A, indicating that 
the role of NUPR1 to counteract necrosis is independent of its anti-apoptotic mechanism. Interestingly, we also 
pre-treated cells with the programmed necrosis inhibitor Necrostatin-1 (Nec-1)23 and we found a greater decrease 
of LDH release in control condition as well as in ER-stress conditions (Fig. 1A). We also used flow cytometry 
after co-labelling cells with Annexin V and PI to measure apoptosis and programmed necrosis, respectively, in 
genetically NUPR1-depleted cells after brefeldin A, thapsigargin or tunicamycin treatment. Transfection with 
siRNAs against NUPR1 increased apoptotic and necrotic events, both in untreated and ER stressor-treated cells 
as showed in Figs 1B,C and S2B, which is in line with the data obtained concerning caspase 3/7 activity and LDH 
release. Inactivation of the NUPR1 expression in Panc-1 cells (Fig. S1B), using a CRISPR-Cas9 knockout strategy, 
we observed a lower growth rate (Fig. S1C). Upon co-labelling cells with Annexin V and PI to measure apoptosis 
and necrosis resulted in similar consequences named greater necrosis and apoptosis, in control condition and 
when cells were challenged to ER-stressors, as shown in Figs 1D,E and S2C. Congruently with that data, after 
reconstitution of NUPR1 expression in CRISPR-Cas9 knockout Panc-1 cells by transfecting a NUPR1-expression 
vector, cell viability was almost completely rescued (Fig. S3). Altogether, these data indicate that inactivation of 
NUPR1 increases the sensitivity of cells to apoptosis and to programmed necrosis, and that the necrotic process 
is independent of caspase 3/7 activation. Thus, this data demonstrate that cell death after inactivation of NUPR1 
occurs by a combination of both, apoptotic and necrotic processes.
NUPR1 down-regulation decreases ATP production. Since the normal production and handling of 
ATP as both an energetic and signaling-associated molecule is vital for cells24, we evaluated if ATP metabo-
lism was implicated in the effects of NUPR1 down-regulation on programmed necrosis and apoptosis. Notably, 
we found that the levels of ATP were significantly reduced in cells transfected with siRNAs against Nupr1, in 
untreated and in ER-stressed cells (Fig. 2A). Moreover, ER-stressors induced a significant decrease of ATP con-
tent in control cells and NUPR1-dowregulated cells compare with untreated cells. Again, inhibition of caspase 
3/7 activity did not prevent this effect. On the other hands, upon inhibiting programmed necrosis by Nec-1 we 
found an almost total rescue of the ATP content in NUPR1-downregulated cells (Fig. 2A). We considered that the 
decrease in the intracellular ATP content might be the result of reduced efficiency of the mitochondrial metabo-
lism or decreased substrate availability for synthesizing these molecules within the cells25. To address this issue, 
we therefore evaluated the mitochondrial oxygen consumption rate (OCR) at basal conditions as well as after 
treatment with an inhibitor of ATP synthase, oligomycin26, or a potent mitochondrial oxidative phosphorylation 
uncoupler, carbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP). Oligomycin treatment allowed the 
calculation of the OCR used by mitochondria exclusively for ATP production, while FCCP injection estimated 
the maximal respiration capacity of this organelle under stress situations. We measured the OCR in pancreatic 
cancer cells with Nupr1 siRNA-mediated knockdown (Fig. 2B) or knockout by CRISPR-Cas9 (Fig. 2C), as well as 
in pancreatic acini obtained from Nupr1-KO and WT mice (Fig. 2D). Interestingly, compared with control cells, 
the OCR was strongly decreased in cells depleted of NUPR1 by siRNAs or CRISPR-Cas9-based knockout at basal 
respiration, as well as at the maximal respiration capacity (Fig. 2B,C). In addition, we found that the OCR was 
(E), annexin V-positive cells (F) and a representative experiment of the dot plot profile of cells was showed  
(G). Data are means of triplicates ± SEM of 3 control and 6 Nupr1 knockout clones. For each treatment, statistically 
significant differences (*p < 0.05, **p < 0.01, ***p < 0.001) from control clones are shown.
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Figure 2. Nupr1 deficiency induces a decrease in ATP production by OXPHOS suppression. MiaPaCa2 cells 
were transfected with siCtrl or two different siRNA against Nupr1 for 48 h. Cells were then incubated with 
thapsigargin, brefeldin A, or tunicamycin at 1 μM for another 24 h period in the presence or not of Z-VAD-
FMK (10 μM) or Nec-1 (40 μM), and ATP production was measured (A); data values were normalized to the 
untreated siCtrl. Data are means of triplicates ± SEM. For each treatment, statistically significant differences 
(*p < 0.05, **p < 0.01, ***p < 0.001) compared to siCtrl with same treatment conditions (#p < 0.05, ##p < 0.01, 
###p < 0.001) compared to non-pretreated cells with Z-VAD-FMK or Nec-1 with same ER-stressor treatment. 
Mitochondrial respiration reflected by oxygen consumption rate (OCR) levels was measured in MiaPaCa2 cells 
transfected with siCtrl, siNUPR1-1 or siNUPR1-2 for 72 h (B). Mitochondrial respiration was also measured in 
three clones of Panc-1 control cells (with wild-type NUPR1), and six clones of Nupr1 knockout cells, developed 
by CRISPR-Cas9 technology. Data are means of triplicates ± SEM of the 3 control and 6 knockout clones  
(C). Finally, we measured mitochondrial respiration in pancreatic acinar cells from WT (Nupr1+/+) and 
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drastically reduced in Nupr1-KO acini isolated from animals compared to those from WT mice (Fig. 2D). Then, in 
order to evaluate if the oxidization of any of the main fuels used by the mitochondria for ATP production, which 
are glutamine, fatty acids, and glucose, could be compromised in NUPR1-inhibited cells, we used the Mito Fuel 
Flex Test. Measurements were obtained of the OCR for the basal respiration by the cells, and subsequently, we 
inhibited glutamine, fatty acid, or glucose metabolism for mitochondrial ATP production with BPTES, etomoxir, 
and UK5099 respectively. A decrease in the OCR after these methods of inhibition would indicate that the cells 
were metabolizing the substrate. Indeed, we found that after the injection of any of these three inhibitors, there 
was a decrease in the OCR in control cells (Fig. 2E). In contrast, in NUPR1-depleted cells, after the inhibition of 
the glutamine, fatty acid, or glucose oxidation, mitochondrial OCR was not modified as shown in Fig. 2E. These 
results indicate that mitochondria are not appropriately oxidizing these substrates to generate ATP in the absence 
of NUPR1. Congruent with these results, we found that the expression of distinct enzymes involved in the tricar-
boxylic acid cycle, such as SDHA, FH, PDHA, and IDH2, was significantly downregulated in NUPR1-depleted 
cells as presented in Fig. 2F. Since O2-dependent ATP production is inefficient in NUPR1-deficient cells, we eval-
uated the energy production by anaerobic glycolysis, measured as the extracellular acidification rate (ECAR) by 
the proton efflux into the media during lactate release. These experiments demonstrated that the ECAR increased 
under basal glycolysis and during inhibition of mitochondrial respiration after oligomycin treatment (glycolytic 
capacity) in NUPR1-depleted cells (Fig. 3A), thereby resulting in lower cellular reserves of glucose. An increase 
in ECAR values was also observed with CRISPR-Cas9 knockout Nupr1 cells, as shown in Fig. 3B, corroborating 
this effect. Furthermore, in pancreatic acini obtained from Nupr1-KO and WT mice, we found that Nupr1−/− acini 
used more anaerobic glycolysis than WT, with a consequent reduction in the intracellular reserve of glucose 
(Fig. 3C). This observation was also confirmed by directly measuring lactate release into the culture media of 
NUPR1-deficient cells (Fig. 3D). We also detected a significant increase in glucose uptake in NUPR1-defficient 
cells (Fig. 3E), whereas glutamine uptake remained unchanged (Fig. 3F). Finally, measuring the OCR and the 
proton production rate by cells in the extracellular medium showed a rate of ATP production by glycolysis in 
control cells of 14.63 ± 1.30 pmoles/min/1000 cells, which represented 12.67% of the total ATP produced. For 
the siNUPR1-1- and siNUPR1-2-transfected cells, the rate was 22.75 ± 1.59 and 22.26 ± 0.80, respectively, which 
represented 32.43% and 30.74% of the total ATP production (Fig. 3G). Accompanying these events, we also found 
that several genes involved in glycolysis, such as PDK, GPI, TPI, PGK1, and PGAM1, increased their expression 
(Fig. 3H). Taken together, these results strongly support a model whereby, under NUPR1 deficiency, the ATP 
production by glucose is switched towards glycolysis due to OXPHOS failure. However, glycolysis is less effi-
cient in terms of ATP production than OXPHOS, and therefore, the glucose reserve is rapidly consumed. Thus, 
NUPR1-depleted cells are limited by intracellular ATP availability, which contributes to the triggering of cell 
death by programmed necrosis.
NUPR1 down-regulation alters the function and localization of mitochondria. The results 
described above demonstrate that NUPR1 down-regulation induces a defect in mitochondrial OXPHOS activity, 
which is evidenced by the strong decrease in O2 consumption and ATP production, even if the cell attempts to 
compensate by activating the production of ATP through glycolysis. Consequently, we further evaluated the 
normal functioning of the mitochondria in cells in which NUPR1 had been genetically inactivated. First, we 
evaluated the proton gradient by measuring the membrane potential using the Mito ID system. In mitochondria, 
proton gradients generate a chemiosmotic potential known as the proton motive force which is used for the 
synthesis of ATP by OXPHOS, Ca2+ uptake, and antioxidant defense. The measurement of the chemiosmotic 
potential is a key indicator of mitochondrial and cell health or injury. In NUPR1-depleted cells, we found a sig-
nificant depolarization of the mitochondrial membrane which is reflected by a decrease in the fluorescence of 
dye, as presented in Fig. 4A,B, which explains, at least in part, the observed defect in ATP production. We then 
measured superoxide anion production by the mitochondria using the MitoSOX reagents, by both fluorescent 
microscopy and flow cytometry. These studies are important since superoxide anion generation by mitochon-
dria triggers oxidative damage and contributes to retrograde redox signaling from the organelle to the rest of 
the cell. In this regard, both flow cytometry and fluorescence microscopy showed a significant increase in the 
intracellular levels of superoxide anions in NUPR1-deficient cells (Fig. 4C,D). Thus, these experiments clearly 
demonstrate that NUPR1 down-regulation affects the function of mitochondria, which explains the impact on 
ATP metabolism described above. The cellular distribution of mitochondria was analyzed in NUPR1-deficient 
cells using the MitoTracker Deep Red reagent counterstained with Alexa Fluor 488 phalloidin for cytoplasm 
and DAPI staining for the nucleus. The images shown that in NUPR1-downregulated cells the mitochondria 
remained localized in a limited perinuclear region, whereas in control cells mitochondria were more homoge-
neously localized throughout the cytoplasm as a structured network (Fig. 5A). Transmission electron micros-
copy analysis of the mitochondria confirmed their limited perinuclear localization and the absence of significant 
Nupr1−/−, mice (D). Only statistically significant differences (p values ≤ 0.05) were shown. The OCR was 
measured under basal conditions or following the addition of oligomycin, FCCP, or rotenone/antimycin A. The 
rates of OCR for basal respiration, maximal respiration, spare capacity, and ATP production were quantified as 
described in the Materials and Methods section. The OCR was again determined in MiaPaCa2 cells transfected 
with siCtrl, siNUPR1-1, or siNUPR1-2 when cells were challenged with UK5099, BPTES, or etomoxir; 
inhibitors of glucose oxidation, glutaminase, and carnitine palmitoyl-transferase 1 A, respectively  
(E). Total RNA was extracted to monitor the mRNA levels of the genes involved in the Krebs cycle using 
RT-qPCR (F). Data are means of triplicates ± SEM. For each treatment, statistically significant differences 
(*p < 0.05, **p < 0.01, ***p < 0.001) from siCtrl are shown.
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Figure 3. Nupr1 deficiency promotes anaerobic glycolytic metabolism. Extracellular acidification rate (ECAR) 
levels were measured in MiaPaCa2 cells transfected with siCtrl, siNUPR1-1, or siNUPR1-2 for 72 h (A). The 
ECAR was measured in three clones of Panc-1 control cells (with wild-type Nupr1) and six clones of Nupr1 
knockout cells, developed by CRISPR-Cas9 technology. Data are means of triplicates ± SEM of three control 
and six knockout clones (B). Statistically significant differences from Panc-1 control cells with p values ≤ 0.05 
are shown. Also, the ECAR was measured in pancreatic acinar cells from WT (Nupr1+/+) and Nupr1−/− mice 
(C). The ECAR was measured under basal conditions or following the addition of glucose, oligomycin, or 
2-Deoxyglucose. The rates of ECAR for glycolysis, glycolytic capacity, and glycolytic reserve were quantified as 
described in the Materials and Methods section. Lactate release (D), glucose (E) and glutamine (F) uptake and 
were measured in the extracellular medium after 24 h in culture. A representative image of DMEM collected 
after 72 h of culture is shown (D). ATP production by OXPHOS and anaerobic glycolysis were determined by 
the OCR and proton production rate, respectively (G); data values were normalized to the siCtrl. Total RNA was 
extracted to monitor mRNA levels of the genes involved in glycolysis using RT-qPCR (H). Data are means of 
triplicates ± SEM. For each treatment, statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001) differences 
from siCtrl (A, D–H), Ctrl CRISPR clones (B) or Nupr1+/+ mice (C) are shown.
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ultrastructural changes of the organelle (Fig. 5B). Through these experiments, we found no apparent change in 
the overall number of mitochondria in NUPR1-deficient cells (Fig. 5C). However, these techniques revealed 
that mitochondria of the NUPR1-deficient cells were almost always associated with the ER, which was enlarged, 
as often observed during ER stress (Fig. 5D). We therefore sought to gain insight into whether this observation 
indeed indicated that Nupr1-defficient cells were undergoing ER stress by measuring intracellular Ca2+ concen-
tration using flow cytometry. Indeed, one of the most typical features of ER stress is the massive Ca2+ release 
from the stressed ER to the cytoplasm, which causes Ca2+ to move from the ER to mitochondria. We found a 
considerable increase in this parameter with values that resemble those found in our positive controls of ER 
Mitochondrial membrane
potential
NU
PR
1-C
trl
clo
ne
s
NU
PR
1-K
O
clo
ne
s
FC
CP
0.0
0.5
1.0
1.5
**
***M
IT
O
-ID
flu
or
es
ce
nc
e
(n
or
m
al
iz
ed
to
N
U
P
R
1-
C
tr
l c
lo
ne
s)
Mitochondrial superoxide
NU
PR
1-C
trl
clo
ne
s
NU
PR
1-K
O
clo
ne
s
0.0
0.5
1.0
1.5
2.0
**
M
ito
S
O
X
flu
or
es
ce
nc
e
(n
or
m
al
iz
ed
to
N
U
P
R
1-
C
tr
l c
lo
ne
s)
Mitochondrial membrane
potential
siC
trl
siN
UP
R1
-1
siN
UP
R1
-2
FC
CP
0.00
0.25
0.50
0.75
1.00
1.25
**
*
***M
IT
O
-ID
flu
or
es
ce
nc
e
(n
or
m
al
iz
ed
to
si
C
tr
l)
Mitochondrial superoxide
siC
trl
siN
UP
R1
-1
siN
UP
R1
-2
0
1
2
3
**
*
M
ito
S
O
X
flu
or
es
ce
nc
e
(n
or
m
al
iz
ed
to
si
C
tr
l)
A B
C D
siCtrl siNUPR1-1 siNUPR1-2 NUPR1-Ctrl clones   NUPR1-KO clones
Figure 4. Nupr1 deficiency leads to a mitochondrial membrane potential disruption inducing ROS 
overproduction. Flow cytometry analysis of MiaPaCa2 cells transfected with siCtrl, siNUPR1-1, or siNUPR1-2 
for 72 h was carried out using MITO-ID for analysis of the mitochondrial membrane potential (A). MITO-ID 
was also applied to three clones of Panc-1 control cells (with wild-type NUPR1) and six clones of Nupr1 
knockout cells, developed by CRISPR-Cas9 technology. Data are means of triplicates ± SEM of the 3 control 
and 6 knockout clones (B). ROS production was detected using MitoSOX Red by flow cytometry analysis in the 
experimental cell groups as described above (C,D). Representative images of the fluorescence microscopy of 
both ROS indicators are shown (C,D). Data are means of triplicates ± SEM. Statistically significant differences 
from siCtrl (*p < 0.05, **p < 0.01, ***p < 0.001) was shown.
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Ca2+ release, namely brefeldin A- or tunicamycin-treated cells (Fig. 5E). The sum of uncontrolled production of 
oxygen radicals and Ca2+ cycling in the cell causes mitochondrial uncoupling and outer membrane permeabili-
zation, ending with the release of intermembrane space proteins, including cytochrome c. In agreement with our 
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Figure 5. Malfunction of mitochondria in NUPR1-deficient cells. MiaPaCa2 cells transfected with siCtrl, 
siNUPR1-1 or siNUPR1-2 for 72 h were loaded with the mitochondrial selective probe MitoTracker Deep Red 
FM and, after fixation, marked with Alexa Fluor 488 Phalloidin and DAPI (A). Representative transmission 
electron microscopy images with different magnifications of the cells are shown. ER-mitochondrial contact or 
not are indicated by red or blue arrows, respectively (B). Mitochondria number per cell was evaluated counting 
them in transmission electron microscopy images; not less than 12 cells were counted for each condition (C). 
The percentage of mitochondria with ER contacts per field (mean of 10 fields) for each condition is shown; not 
less than 250 mitochondria were counted (D). Flow cytometry analysis was carried out using Fluo-4-AM for 
analysis of the cytosolic calcium concentration (E). Total RNA was extracted to monitor mRNA levels of the 
genes involved in the mitochondrial dynamic (F). Data are means of triplicates ± SEM. Statistically significant 
differences from siCtrl (*p < 0.05, **p < 0.01, ***p < 0.001) was shown.
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previous data, measuring of cytochrome c release in NUPR1-depleted cells shown was greater compared to con-
trol cells (Fig. S4A). In this regard, the members of the Bcl-2 family proteins play an important role are classified 
in two subfamilies with antagonistic functions: the Bcl-2-like survival factors and the Bax-like death factors. In 
our results, we found that upon NUPR1 downregulation, the expression of Bcl-2-like survival factors like BCL-2, 
MCL1 and BCLXL shown non-significant differences compared with control cells. On the other hand, Bax-like 
death factors such as BAX and BAK1 were overexpressed after NUPR1 depletion (Fig. S4B). Concomitantly, we 
found a significant downregulation in the expression of two genes: TFAM, which encodes a key mitochondrial 
transcription factor that functions in mitochondrial DNA replication and repair, and NRF1, which encodes a 
transcription factor that activates expression of nuclear genes required for respiration and mitochondrial DNA 
transcription and replication (Fig. 5F). In contrast, expression of LONP1, a gene encoding a mitochondrial pro-
tease involved in the selective degradation of misfolded, unassembled, or oxidatively damaged polypeptides in the 
mitochondrial matrix, and PINK1, a gene encoding for a serine/threonine protein kinase that is thought to pro-
tect cells from stress-induced mitochondrial dysfunction, were overexpressed (Fig. 5F). Altogether, these results 
reveal a malfunction and abnormal subcellular distribution of mitochondria which may be due to the massive 
Ca2+ release from the stressed ER in NUPR1-deficient cells.
NUPR1 down-regulation induces failures in ER stress response. Nupr1 expression is strongly 
induced in response to ER stress, but its role in ER stress response, if any, remains to be established. In fact, the 
ER stress response is accompanied by the activation of several ER stress-associated genes27, with unknown roles 
in this process for some of them. We therefore evaluated the role of NUPR1 in the ER stress response using sev-
eral complementary approaches. The transcriptome of the MiaPaCa2 cells treated with a siRNA against Nupr1 
revealed a downregulation of several genes involved in ER stress-associated pathways when analyzed by both 
the Ingenuity Pathways Analysis (http://www.ingenuity.com/) and STRING28 bioinformatics tools. The most 
significant biological pathways identified as inefficiently activated in NUPR1-deficient cells were: the response 
to unfolded protein (30 mRNA downregulated, FDR 7.53e-40), protein folding (28 mRNA downregulated, 
FDR = 1.1e-32), the ER unfolded protein response (17 mRNA downregulated, FDR = 1.55e-19), regulation of 
translational initiation (13 mRNA downregulated, FDR = 2.95e-15), response to ER stress (16 mRNA down-
regulated, FDR 9.98e-14), the ER-nucleus signaling pathway (8 mRNA downregulated, FDR = 1.48e-10), the 
ATF6-mediated unfolded protein response (6 mRNA downregulated, FDR = 1.48e-10), the PERK-mediated 
unfolded protein response (6 mRNA downregulated, 1.33e-09), chaperone-mediated protein folding (8 mRNA 
downregulated, FDR = 2.17e-09), response to stress (32 mRNA downregulated, FDR = 5.97e-06), and the 
IRE1-mediated unfolded protein response (6 mRNA downregulated, FDR = 2.14e-05) (see Tables 1 and S1). 
These experiments, designed to directly evaluate the effects of NUPR1 in exocrine pancreatic cells, demonstrate 
MiaPaCa2 treated with siNUPR1
Pathway ID Biological process Downregulated genes FDR
GO:0006986 Response to unfolded protein 30 7.53e-40
GO:0006457 Protein folding 28 1.1e-32
GO:0030968 Endoplasmic reticulum unfolded protein response 17 1.55e-19
GO:0006446 Regulation of translational initiation 13 2.95e-15
GO:0034976 Response to endoplasmic reticulum stress 16 9.98e-14
GO:0006984 Er-nucleus signaling pathway 8 1.48e-10
GO:0036500 Atf6-mediated unfolded protein response 6 1.48e-10
GO:0036499 Perk-mediated unfolded protein response 6 1.33e-09
GO:0061077 Chaperone-mediated protein folding 8 2.17e-09
GO:0006950 Response to stress 32 5.97e-06
GO:0036498 Ire1-mediated unfolded protein response 6 2.14e-05
NUPR1−/− mice
Pathway ID Biological process Downregulated genes FDR
GO:0034976 Response to endoplasmic reticulum stress 10 7.73e-12
GO:0006986 Response to unfolded protein 7 6.82e-09
GO:0006457 Protein folding 7 6.81e-07
GO:0030968 Endoplasmic reticulum unfolded protein response 5 1.94e-06
GO:0044267 Cellular response to unfolded protein 5 2.15e-06
GO:0006950 Response to stress 12 0.00255
Table 1. Nupr1-deficiency induces a downregulation of the ER stress-associated pathways in vitro and in vivo.
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that gene expression networks associated to ER stress are among the top pathways associated with expression 
changes under these conditions. To confirm these experiments in vivo, we made use of the Nupr1-KO mice model. 
Interestingly, transcriptomic analysis of pancreas from these mice analyzed using the same bioinformatics tools, 
also revealed an inefficiency in the ER stress response, for some of these biological processes, such as: the response 
to ER stress (10 mRNA downregulated, FDR = 7.73e-12), response to unfolded protein (7 mRNA downregu-
lated, FDR 6.82e-09), protein folding (7 mRNA downregulated, FDR = 6.81e-07), ER unfolded protein response 
(5 mRNA downregulated, FDR = 1.94e-06), cellular response to unfolded protein (5 mRNA downregulated, 
FDR = 2.15e-06), and response to stress (12 mRNA downregulated, FDR = 0.00255) (see Tables 1 and S2). Thus, 
these results from our animal model, combined with those obtained in cells, show that NUPR1 deficiency mounts 
an inefficient ER stress response.
Subsequently, we measured the expression of several genes involved in controlling the ER stress response, in 
NUPR1-depleted MiaPaCa2 cells, the ER sensors: ATF6, IRE1α, PERK, as well as ER downstream effectors and 
target: EIF2A, XBP1, ATF4, CANX, CALR, CHOP, HERPUD1, EDEM1, HPS90B1, GADD34, HSPA5 and HSP90 
by RT-qPCR. Notably, some of these genes demonstrated significantly decreased expression in the absence of 
NUPR1 expression although not GADD34, HSPA5 (BIP) and HSP90 (Fig. 6A). In addition, expression of ATF6, 
IRE1α, PERK and BIP proteins was also measured by western blot on the siNUPR1-1- and siNUPR1-2-treated 
MiaPaCa2 cells. Interestingly, whereas levels of ATF6, IRE1α and PERK were decreased in NUPR1-depleted 
cells, BIP protein levels remained unaffected in strong correlation with its mRNA (Fig. 6B). Altogether, these data 
suggest that expression of NUPR1 is necessary for an optimal ER stress response, which occurs, at least in part, 
through control of these genes at the transcriptional level. Therefore, when NUPR1 is down-regulated, the ER 
stress response is suboptimal, with dramatic consequences on mitochondrial function and a strong deficit in ATP 
production, and as main consequence, cell death by programmed necrosis is induced.
Figure 6. NUPR1 deficiency induces a decrease in the expression of ER stress genes. Total RNA was extracted 
from MiaPaCa2 cells transfected with siCtrl, siNUPR1-1 or siNUPR1-2 for 72 h to evaluate the mRNA levels 
of the genes involved in ER stress response using RT-qPCR (A). Western blot analysis was performed to 
evaluated protein levels of expression of IRE1α, ATF6, PERK and BIP in NUPR1-depleted cells. Data are means 
of triplicates ± SEM. Statistically significant differences from siCtrl (*p < 0.05, **p < 0.01, ***p < 0.001) was 
shown.
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NUPR1 expression protect acinar cells of necrosis in mice with acute pancreatitis. During the 
course of pancreatitis, there is a sustained ER stress and pathological calcium signaling29. Thus, we analyzed 
the effects of NUPR1 down-regulation on cell death induced by experimental pancreatitis in Nupr1-knockout 
(KO) and WT mice. As shown in Fig. 7A,B, we found that acute pancreatitis, induced by repeated injections of 
caerulein, resulted in a higher serum concentration of lipase (i.e.: 1248 ± 39 U/L and 715 ± 45 U/L after 12 h of 
induction in KO and WT mice respectively; p = 0.0009) and lactate dehydrogenase (LDH) (i.e.: 4247 ± 198 ng/ml 
and 2034 ± 119 ng/ml after 12 h of induction in KO and WT mice respectively; p = 0.002). Congruent with a role 
of NUPR1 in cell death by necrosis in acute pancreatitis, Nupr1-KO mice displayed a higher necrosis as well as 
necrotic score when compared with wild type littermates (Fig. 7C). Thus, this in vivo experiment demonstrates 
that normal levels of NUPR1 are necessary for protecting pancreatic cells from necrotic cell death.
Discussion
The current study significantly contributes to a better understanding of mechanisms underlying the regulation of 
cell death by the cancer-associated protein, NUPR1. Our data support the idea that NUPR1 activation is strongly 
involved in protecting the cell against programmed cell death by both apoptosis and programmed necrosis, and 
therefore, targeting NUPR1 protein in cancer appears to be a promising tool as an anticancer therapeutic strat-
egy. Several empiric observations have shown that cancer cells undergo growth arrest or cell death after genetic 
inactivation of NUPR1 in vitro and in vivo8,14–18. However, to date, the mechanisms responsible for the biological 
consequences of its inactivation in cancer cells remain poorly understood. In this work, we used a battery of 
complementary methodological approaches to study these mechanisms, including Nupr1-KO mice, two siRNA 
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Figure 7. Nupr1 protects from pancreatitis-induced cell death. Serum lipase (A) and LDH (B) levels were 
measured in control Nupr1+/+ and Nupr1−/− mice at 6, 12, 18, and 24 h following caerulein-induced acute 
pancreatitis. The necrosis score (C) was evaluated in histologic sections of pancreases and it refers to ranges of 
the percentages of cells involved: 0 = 0-5%; 1 = 5–15%; 2 = 15–35%; 3 = 35–50%; 4 ≥ 50%. Histological pictures 
of the pancreases by H&E staining at 0 and 18 hours post-induction of pancreatitis are shown. Data are means of 
triplicates ± SEM. For each treatment, statistically significant differences (*p < 0.05, **p < 0.01, ***p < 0.001) 
from Nupr1+/+ mice are shown.
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sequences and CRISPR-Cas9 to inhibit NUPR1 expression with systematically concordant results. We demon-
strate that the down-regulation of Nupr1 in pancreatic cells promotes a cascade of events with several important 
consequences. NUPR1 down-regulation prevents pancreatic cells from properly ER stress response, through the 
inappropriate expression of several ER stress-associated genes leading to a programmed cell death. Moreover, cell 
death is induced by metabolic changes resulting in lower ATP production, higher consumption of glucose and a 
partial switch from OXPHOS to glycolysis due to a mitochondrial failure.
Mitochondria and ER form structural and functional networks (mitochondria-associated ER membranes 
(MAMs)) essential to maintain cellular homeostasis and determine cell fate under stress conditions. Ca2+ is 
transferred from the ER to the mitochondria and this process is very important to activate prosurvival/pro-
death pathways30. In this regard, we found that NUPR1 inactivation triggers a massive release of Ca2+ from the 
ER to the cytosol and we also observed a perinuclear relocalization of mitochondria to the vicinity of the ER 
in NUPR1-deficient cells. However, this adaptive attempt of the mitochondrial network to counteracted the 
increased Ca2+ concentration in the cytoplasm, which as shown previously31, leads to an increased mitochon-
drial Ca2+ concentration, disruption of mitochondrial membrane potential, leak of electrons from the respiratory 
chain in the complexes I and III32, ultimately resulting in a ROS accumulation, cytochrome c release, and, most 
importantly, in lower ATP generation. The low level of ATP production by NUPR1-deficient cells seems to be 
partially compensated by switching the remaining glucose consumption to anaerobic glycolysis. Currently, the 
consensus in the cancer metabolism field is that mitochondrial metabolism is totally required for tumor growth 
tumor. In cancer cells, mitochondria are important providers of energy and building blocks for tumor anabolism, 
also control redox and calcium homeostasis, participate in transcriptional regulation, and govern cell death33. 
Notably, loss of function in genes encoding OXPHOS enzymes, make these cancer cells switch on glycolysis for 
ATP production34 as well as when mitochondrial respiratory inhibitors, like rotenone or FCCP, or drugs like 
phenformin are used, they stimulate lactate production, what impose an energetic stress on cancer cells and sup-
press the cell growth35,36. Thus, mitochondria constitute a promising target for anticancer therapies. In this regard, 
after NUPR1 inhibition we observed a mitochondrial metabolism failure and mitochondrial dysfunctions and 
cancer cells switch on glycolysis for energy production. However, this adaptive response in NUPR1-deficient cells 
is insufficient to survive and therefore a metabolic cell death ensues. Moreover, we previously demonstrated that 
deficiency in NUPR1 expression results in induction of cellular cannibalism37 and autophagy38 processes. In light 
of the results from the current study, it is tempting to speculate that both cannibalism and autophagy could serve 
to generate energy fuel in NUPR1-deficient cells to compensate for the ATP deficiency. In addition, since intracel-
lular ATP deficiency is accompanied by an increase in AMP and therefore activation of AMPK, it is possible that 
this kinase signals the initiation of the autophagy39 and cellular cannibalism processes40.
A metabolism-associated role of NUPR1 was previously suggested in hepatocellular carcinoma, in which 
expression of Nupr1 is induced in response to the mitochondrial malfunction, and consequently, NUPR1 overex-
pression favors cancer progression41,42. In addition, it was also demonstrated that NUPR1 overexpression is neces-
sary in the liver for an optimal response to a non-essential aminoacids-deficient diet and in pancreatic cancer cells 
to a starved culture media5,43. Based on these observations, we can assume that overexpression of NUPR1 operates 
to improve mitochondrial function to produce a maximum of energy in the presence of low substrates under 
stressed conditions. Moreover, cell death after NUPR1 depletion is driven by apoptosis and mainly programmed 
necrosis due to the lack of ATP. Furthermore, when NUPR1-deficient cells were challenged to ER-stressor, they 
were more sensitive to these treatments increasing both apoptosis and necrosis. ER stress is widely reported to 
induce caspase-dependent apoptotic cell death but ER stress induction by chemical triggers such as brefeldin A, 
thapsigargin and tunicamycin also induce regulated necrosis44. Importantly, only inhibition of programmed necro-
sis by Nec-1 (but not with apoptotic inhibitor) rescued NUPR1-depleted cells and increased the ATP content. In 
this regard NUPR1 plays an important role protecting cells from ER-stress programmed cell death, mediating a 
pro-survival response by a transcriptional activation of genes encoding ER-stress sensors and effectors.
Previous investigations in our team described NUPR1 as a protective factor against pancreatitis-induced 
lesions by activating expression of the anti-inflammatory factor pancreatitis associated protein I (also known 
as PAPI or Reg3beta)45, in part through regulating its transcriptional activation. In turn, PAPI/Reg3beta 
inhibits the activation of NFkappaB in macrophages and therefore acts as a powerful anti-inflammatory fac-
tor46. Consequently, the anti-inflammatory effect of NUPR1 could be explained through the activation of the 
PAPI/Reg3beta. Surprisingly, in this work we are demonstrating that experimental pancreatitis induced in 
NUPR1-deficient mice results in a significant increase in programmed necrosis as indicated by the greater 
release of LDH, amylase and lipase in blood during the acute phase of the disease and by the significant increased 
necrotic score. Altogether, these results strongly suggest that induction of NUPR1 during acute pancreatitis con-
trols both, inflammation and necrosis, by two different and complementary mechanisms.
In conclusion, this current work demonstrates that, in NUPR1-deficient cells, there is a decrease in ATP pro-
duction and glucose consumption is switched towards glycolysis instead of OXPHOS. This defect is due to a 
mitochondrial malfunction, coupled with a deficient ER stress response. This cascade of processes promotes 
programmed cell death, what makes NUPR1 and interesting target for cancer treatment.
Materials and Methods
Animals. Nupr1–/– mice bear a homozygous deletion of exon 2 and have been reported previously47. The Pdx1-
cre; LSL-KrasG12D mice were provided by R. Depinho (Dana-Faber Cancer Institute, Boston, Massachusetts, USA) 
and resulted from crossbreeding of the Pdx1-Cre and LSL-KrasG12D strains. Mice were kept in the Experimental 
Animal House of the Centre de Cancérologie de Marseille (CRCM) of Luminy. All experimental procedures on 
animals were approved by the Comité d’éthique de Marseille numéro 14 and in accordance with the European 
Union regulations for animal experiments.
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Induction of experimental pancreatitis. Pancreatitis was induced in 4-month-old Nupr1−/− and 
Nupr1+/+ mice weighing 20–24 g. Caerulein (Sigma) was administered as intraperitoneal injections of 50 μg/kg 
body weight, as previously described48. Saline-injected animals served as controls.
Preparation of isolated pancreatic acinar cells. Briefly, 5-week-old mice pancreata were immediately 
removed after euthanasia, cut into small sections, and digested with collagenase IA (Sigma-Aldrich) for 10 min at 
37 °C as previously described49. Acini were collected by centrifugation at 30 g for 5 min, washed and resuspended 
in Seahorse medium, and plated in pre-coated Cell Tak (Corning) Seahorse plates (Agilent).
Preparation of serum and tissue samples. Mice were sacrificed at several time points from 3 to 24 h 
following the first intraperitoneal injection of cerulein. Whole blood samples were centrifuged at 4 °C, and serum 
was stored at −80 °C. The pancreas was removed on ice, immediately frozen in liquid nitrogen, and stored at 
−80 °C.
Necrosis score evaluation. Formalin-fixed samples were embedded in paraffin and 5-μm sections were 
stained with hematoxilin and eosin. The histological alterations in the sections were scored by three experienced 
reviewers. The scores refer to ranges of percentages of cells involved from 0 (absent), 1 (minimal, 0 to 15%), 2 
(moderate, 15 to 35%), 3 (important, 35 to 50%) to 4 (maximal, > 50%).
LDH and lipase serum concentration. A Cobas analyzer was used to measure enzyme concentrations 
in the serum samples of Nupr1−/− and Nupr1+/+ mice, according to the manufacturer’s specifications and using 
proprietary reagents.
RNA-seq. RNA from pancreata of 5-week-old mice was purified following the procedure of Chirgwin et al.50. 
RNA integrity was assessed using the Agilent 2100 Bioanalyzer with the RNA 6000 Nano chip Kit. Samples were 
sent to the Transcriptomic and Genomic platform of Marseille-Luminy (TGML). The enrichment of mRNA, 
cDNA library construction for RNA-seq, sequencing, and bioinformatic data analysis were performed as previ-
ously described51.
Cell culture. MiaPaCa2 and Panc1 cells were obtained from the American Type Culture Collection and main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Life Technologies) supplemented with 10% fetal 
bovine serum (Lonza) at 37 °C with 5% CO2.
siRNA transfection. Cells were plated at 70% confluence and INTERFERin reagent (Polyplus-transfection) 
was used to perform siRNA transfections, according to the manufacturer’s protocol. Scrambled siRNA that targets 
no known gene sequence was used as a negative control. All assays were carried out 72 h post-transfection. The 
sequences of Nupr1-specific siRNA were siNUPR1-1 r(GGAGGACCCAGGACAGGAU)dTdT and siNUPR1-2 
r(AGGUCGCACCAAGAGAGAA)dTdT.
CRISPR-Cas9 clones development. Cells were seeded in 12-well plates and transfected with 1 µg of Nupr1 
double nickase plasmid or double control nickase plasmid (Santa Cruz Biotechnology), using Lipofectamine 3000 
Transfection Reagent (Thermo Fisher Scientific) in each well, following the manufacturer’s protocol. Transfected 
cell selection was performed with puromycin and, after 72 h, single cell colonies were isolated. Complete allelic 
knockouts were confirmed using Sanger sequencing.
NUPR1 expression vector transfection. Panc1 cells (clones C1, NUPR1-KO1 and NUPR1-KO2) 
were seeded in 12-well plates and transfected with 2 µg of DNA (NUPR1-FLAG or control vector) and 2 μL 
of Lipofectamine 3000 Transfection Reagent (Thermo Fisher Scientific) per well. Cells were assayed after 24 h 
post-transfection.
LDH assay, ATP production, and caspase-3/7 activity assay. Cells were seeded at a density of 10,000 
cells per well in 96-well plates. Cells were allowed to attach overnight and treated the next day for 24 h. At the end 
of the experiment, LDH release, ATP production, and caspase-3/7 activity were monitored using CytoTox-ONE 
(Promega G7890), CellTiter-Glo (Promega G7571) and Caspase-Glo 3/7assay (Promega G8091), respectively. 
Data were normalized to the cell number.
RT-qPCR. RNA from cells was isolated using Trizol reagent (Invitrogen) and reverse-transcribed using Go 
Script (Promega) according to the manufacturer’s instruction. Real-time quantitative PCR (RT-qPCR) was per-
formed in a Stratagene MXPro-MX3005P using Promega reagents. Primer sequences are available upon request.
Western blot. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose filters, revealed with ECL 
and detected using a Fusion FX7 imager (Vilber-Lourmat, France). The following antibodies were used: rabbit 
monoclonal anti-PERK (C33E10, CTS), rabbit polyclonal anti-BIP (C50B12, CTS), rabbit polyclonal anti-IRE1α 
(14C10, CTS), rabbit monoclonal anti-ATF6 (D4Z8V, CST), rabbit polyclonal anti-human NUPR1 antibody 
(home made) and anti-β-actin (A5316, Sigma).
Extracellular flux assay. Measurements were performed using a Seahorse Bioscience XF24 Extracellular 
Flux Analyzer. This system allowed measurement of the cellular oxygen consumption rate (OCR, in pmoles/
min), the extracellular acidification rate (ECAR in mpH/min) and the proton production rate (PPR). Cells were 
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plated at 30,000 cells/well onto Seahorse 24-well plates 48 h before the assay. OCR was measured using the XF 
Cell Mito Stress Test Kit under basal conditions, and in response to 1 μM oligomycin and 0.25 or 0.5 μM of 
carbonylcyanide p-(trifluoro-methoxy) phenylhydrazone (FCCP) in MiaPaCa2 or pancreatic acini, respectively. 
Oligomycin injection allowed calculation of the OCR for ATP production, and FCCP treatment gave two indexes; 
the maximal OCR capacity and the spare respiratory capacity. Finally, OCR was stopped by adding the electron 
transport chain inhibitors rotenone and antimycin A (0.5 μM each). ECAR was measured using the Seahorse XF 
Glycolysis Stress Test Kit. Glycolysis was calculated as the difference between the values of ECAR upon glucose 
addition (10 mM) and basal ECAR. Glycolytic capacity was calculated as the difference between ECAR following 
the injection of 1 μm oligomycin, and the basal ECAR. Finally, glycolytic reserve was calculated as the difference 
in ECAR between glucose and oligomycin injections. At the end of the experiment, glycolysis was stopped by 
adding 2-Deoxyglucose (100 mM). The contribution of OXPHOS and glycolysis to ATP production was calcu-
lated using the OCR and PPR as previously described52. The Seahorse XF Mito Fuel Flex Test was used to deter-
mine the rate of oxidation of each fuel by measuring OCR. Inhibitors of glutaminase (BPTES 3 μM), carnitine 
palmitoyl-transferase 1 A (Etomoxir 4 μM), and glucose oxidation (UK5099 2 μM) were used. Levels of OCR and 
ECAR were normalized to the cell number.
Lactate release, and glucose and glutamine uptake. The culture media was examined for levels of 
glucose, glutamine, and lactic acid using the YSI 2900 Biochemistry Analyzer (YSI Life Sciences, Yellow Springs, 
OH, USA) following the manufacturer’s instructions. The increase in lactate production was calculated by sub-
tracting the lactate present in the control medium (without exposure to cells) from the lactate present in the 
experimental media. Glucose and glutamine uptake were calculated by subtracting the level of the experimental 
media from the level of the control medium.
AnnexinV/PI staining. Cells were collected after incubation for 24 h with the stimuli. Cells were washed with 
PBS, then detached with Accutase (Gibco, Life Technologies), and resuspended in 100 μl of 1X Annexin-binding 
buffer. Pacific-Blue Annexin V (5 μl, BioLegend) was added to the cell suspension and after a 15-min incuba-
tion at room temperature, 400 μl of 1X Annexin-binding buffer was added. Before analysis by flow cytometry, 
propidium iodide (5 μl, Miltenyi Biotec) was added to the suspension. 10,000 events per sample were collected 
in a MACSQuant-VYB (Miltenyi Biotec, Surrey, UK). Data analysis was performed using the FlowJo software.
Superoxide anion production by the mitochondria. MitoSOX (Molecular Probes) was added to a final 
concentration of 5 μM for 10 min. After incubation, cells were washed with warm PBS, detached with Accutase, 
and resuspended in HBSS (Gibco, Life Technologies) for flow cytometry; or fixed with 4% paraformaldehyde 
for 10 min at room temperature and mounted using Prolong Gold antifade reagent with DAPI (Invitrogen). In 
cytometry experiments, 10,000 events per sample were collected in a MACSQuant-VYB and data analysis was 
performed using FlowJo software. Image acquisition of mounted samples was carried out on a microscope Nikon 
Eclipse 90i fluorescence microscope.
Mitochondrial membrane potential. Measurement was performed using the MITO-ID Membrane 
potential detection kit (ENZ-51018) according to the manufacturer’s protocol. Briefly, cells were collected, 
washed, and preincubated in 500 μl of the Assay Solution containing 5 μl of MITO-ID MP Detection Reagent for 
15 min. After this, 10,000 events per sample were collected in a MACSQuant-VYB and orange fluorescence data 
analysis was performed using the FlowJo software.
Cytosolic calcium concentration. Cells were preincubated with Fluo-4 AM (Molecular Probes) for 30 min 
at 37 °C. Then, cells were washed and resuspended in HBSS for flow cytometry analysis. 10,000 events per sam-
ple were collected in a MACSQuant-VYB and data analysis from flow cytometry was performed using FlowJo 
software.
Mitochondrial network. Localization of the mitochondrial network was assayed by incubation of cells 
in the presence of MitoTracker DeepRed FM (200 nM, Molecular Probes) at 37 °C for 30 min. Then, cells were 
washed twice with PBS and fixed with 4% paraformaldehyde. Cells were subsequently permeabilized, incubated 
with 1% BSA and after, with Alexa Fluor 488 Phalloidin, according to the manufacturer’s instructions. Finally, 
samples were mounted using the Prolong Gold antifade reagent with DAPI. Confocal images were acquired using 
an inverted microscope equipped with LSM 880 with Airyscan detector controlled by Zeiss Zen Black, 63x lens.
Electron microscopy. Samples were prepared using the NCMIR protocol for SBF-SEM53. 70 nm-ultrathin 
sections were prepared using a Leica UCT Ultramicrotome (Leica, Austria) and deposited on formvar-coated slot 
grids. The grids were observed in an FEI Tecnai G2 at 200 KeV and acquisition was performed on a Veleta camera 
(Olympus, Japan).
Cytochrome c release. Measurement was performed using the Cytochrome c Release Apoptosis Assay Kit 
(QIA87) according to the manufacturer’s protocol. Briefly, cells were collected, and treated with permeabilization 
buffer, the released cytochrome c was quickly washed out from cells and that which remained in the mitochondria 
was immunolabeled after fixing the cells. 10,000 events per sample were collected in a MACSQuant-VYB and data 
analysis from flow cytometry was performed using FlowJo software.
DNA microarray. Total RNA (15 μg) was isolated and reverse transcribed for hybridization to the human 
oligonuleotide array U133 Plus 2.0 (Genechip, Affymetrix) as described previously54. Arrays were processed using 
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the Affymetrix GeneChip Fluidic Station 450 and scanned using a GeneChip Scanner 3000 G7 (Affymetrix). 
The GeneChip Operating Software (Affymetrix GCOS v1.4) was used to obtain chip images with quality control 
conducted using the AffyQCReport software.
Statistics. Statistical analyses were performed using the unpaired 2-tailed Student t test and non-normal dis-
tribution. A p value less than or equal to 0.05 was considered significant. All values are expressed as mean ± SEM. 
RT-qPCR data are representative of at least three independent experiments with technical triplicates completed.
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